Amir Horowitz

Prof. Amir Horowitz


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Cancer Cell
Verified
Journal Article
Closed access
BSBérengère Salomé
Bérengère Salomé
JSJohn P. Sfakianos
John P. Sfakianos
DRDaniel Ranti
Daniel Ranti
JDJorge Daza
Jorge Daza
CBChristine Bieber
Christine Bieber
AHAmir Horowitz
Amir Horowitz

1 January 2012 in Frontiers in Immunology
Verified
Journal Article
Open access
AHAmir Horowitz
Amir Horowitz
KSKerstin A. Stegmann
Kerstin A. Stegmann
EREleanor M. Riley
Eleanor M. Riley
Natural killer (NK) cells are large granular lymphocytes that express a diverse array of germline encoded inhibitory and activating receptors for MHC Class I and Class I-like molecules, classical co-stimulatory ligands, and cytokines. The ability of NK cells to be very rapidly activated by inflammatory cytokines, to secrete effector cytokines, and to kill infected or stressed host cells, suggests that they may be among the very early responders during infection. Recent studies have also identified a small number of pathogen-derived ligands that can bind to NK cell surface receptors and directly induce their activation. Here we review recent studies that have begun to elucidate the various pathways by which viral, bacterial, and parasite pathogens activate NK cells. We also consider two emerging themes of NK cell–pathogen interactions, namely their contribution to adaptive immune responses and their potential to take on regulatory and immunomodulatory functions.

21 December 2020 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
ACAndrew J Charap
Andrew J Charap
TETomohiro Enokida
Tomohiro Enokida
RBRachel Brody
Rachel Brody
JSJohn Sfakianos
John Sfakianos
BMBrett Miles
Brett Miles
AHAmir Horowitz
Amir Horowitz
Head and neck squamous cell carcinoma (HNSCC) encompasses a set of cancers arising from the epithelia of the upper aerodigestive tract, accounting for a significant burden of disease worldwide due to the disease’s mortality, morbidity, and predilection for recurrence. Prognosis of HNSCC in the recurrent and/or metastatic (R/M-HNSCC) setting is especially poor and effective treatment options increasingly rely on modulating T-cell antitumor responses. Still, immunotherapy response rates are generally low, prompting the exploration of novel strategies that incorporate other effector cells within the tumor microenvironment. Within the last decade, important advances have been made leveraging the powerful innate antitumor function of natural killer (NK) cells to treat solid tumors, including head and neck squamous cell carcinoma. NK cells are hybrid innate-adaptive effector cells capable of directly eliminating tumor cells in addition to initiating adaptive antitumor immune responses. In the setting of HNSCC, NK cells are important for tumor surveillance and control, and NK cell infiltration has repeatedly been associated with a favorable prognosis. Yet, HNSCC-infiltrating NK cells are susceptible to an array of immune evasion strategies employed by tumors that must be overcome to fully realize the antitumor potential of NK cells. We believe that a conceptual framework informed by the basic biological understanding of the mechanisms underlying NK cell activation can improve treatment of HNSCC, in part by selecting for patients most likely to respond to NK cell-based immunotherapy. Herein, we review the activity of NK cells in HNSCC, paying special attention to the role of environmental and genetic determinants of NK cell antitumor function. Moreover, we explore the evidence that NK cells are a crucial determinant of the efficacy of both established and emerging treatments for HNSCC.

1 February 2021 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
JSJohn P. Sfakianos
John P. Sfakianos
BSBerengere Salome
Berengere Salome
JDJorge Daza
Jorge Daza
AFAdam Farkas
Adam Farkas
NBNina Bhardwaj
Nina Bhardwaj
AHAmir Horowitz
Amir Horowitz

3 July 2024 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
BGBruno Giotti
Bruno Giotti
KDKomal Dolasia
Komal Dolasia
WZWilliam Zhao
William Zhao
PCPeiwen Cai
Peiwen Cai
RSRobert Sweeney
Robert Sweeney
ATAlexander M. Tsankov
Alexander M. Tsankov
Immunotherapies have shown great promise in pleural mesothelioma (PM), yet most patients still do not achieve significant clinical response, highlighting the importance of improving the understanding of the tumor microenvironment (TME). Here, we utilized high-throughput, single-cell RNA sequencing (scRNA-seq) to de novo identify 54 expression programs and construct a comprehensive cellular catalog of the PM TME. We found four cancer-intrinsic programs associated with poor disease outcome and a novel fetal-like, endothelial cell population that likely responds to VEGF signaling and promotes angiogenesis. Across cellular compartments, we observe substantial difference in the TME associated with a cancer-intrinsic sarcomatoid signature, including enrichment in fetal-like endothelial cells, CXCL9+ macrophages, and cytotoxic, exhausted, and regulatory T cells, which we validated using imaging and bulk deconvolution analyses on independent cohorts. Finally, we show, both computationally and experimentally, that NKG2A:HLA-E interaction between NK and tumor cells represents an important new therapeutic axis in PM, especially for epithelioid cases. Significance: This manuscript presents the first single-cell RNA sequencing atlas of PM tumor microenvironment. Findings of translational relevance, validated experimentally and using independent bulk cohorts, include identification of gene programs predictive of survival, a fetal-like endothelial cell population, and NKG2A blockade as a promising new immunotherapeutic intervention in PM.

7 June 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MTMichelle A. Tran
Michelle A. Tran
DYDina Youssef
Dina Youssef
SSSanjana Shroff
Sanjana Shroff
DCDisha Chowhan
Disha Chowhan
KBKristin G Beaumont
Kristin G Beaumont
NBNina Bhardwaj
Nina Bhardwaj
Due to bladder tumors’ contact with urine, urine-derived cells (UDCs) may serve as a surrogate for monitoring the tumor microenvironment (TME) in bladder cancer (BC). However, the composition of UDCs and the extent to which they mirror the tumor remain poorly characterized. We generated the first single-cell RNA-sequencing of BC patient UDCs with matched tumor and peripheral blood mononuclear cells (PBMC). BC urine was more cellular than healthy donor (HD) urine, containing multiple immune populations including myeloid cells, CD4+ and CD8+ T cells, natural killer (NK) cells, B cells, and dendritic cells (DCs) in addition to tumor and stromal cells. Immune UDCs were transcriptionally more similar to tumor than blood. UDCs encompassed cytotoxic and activated CD4+ T cells, exhausted and tissue-resident memory CD8+ T cells, macrophages, germinal-center-like B cells, tissue-resident and adaptive NK cells, and regulatory DCs found in tumor but lacking or absent in blood. Our findings suggest BC UDCs may be surrogates for the TME and serve as therapeutic biomarkers.